A Study of Efficacy and Safety of Glofitamab in Combination With Salvage Therapy in a Real-world Setting in Chinese Adult Patients With Relapsed or Refractory B-cell Non-Hodgkin Lymphoma.
The First Affiliated Hospital of Soochow University
Age
18–any
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
Be diagnosed as B-NHL
Relapse or refractory to previous treatment
Participants who will be treated with glofitamab
You may not be if
Participant who currently participates in or with plan to participate in any interventional clinical trial
Any other reason that, in the investigator's opinion, makes the participant unsuitable to participate in this study.
Clareo Health | A Study of Efficacy and Safety of Glofitamab in Combination With Salvage Therapy in a Real-world Setting in Chinese Adult Patients With Relapsed or Refractory B-cell Non-Hodgkin Lymphoma.
